Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    SoundHealth Raises $12.25M to Expand Non-Invasive Medical Wearables

    29. Juli 2026

    Oxford Spinout Mirae Secures $5.4M to Scale AI Chronic Care Platform

    29. Juli 2026

    A Promising Future for Alzheimer’s Patients

    29. Juli 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»Health»Heartflow’s IPO raises $364M | MedTech Dive
    Health

    Heartflow’s IPO raises $364M | MedTech Dive

    HealthradarBy Healthradar12. August 2025Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Heartflow’s IPO raises 4M | MedTech Dive
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Dive Brief:

    • Heartflow’s initial public offering grossed $364.2 million after the volume and price of the shares sold exceeded the original expectations.
    • The company listed last week and completed the sale of the overallotment on Monday, adding almost $50 million through the sale of additional shares.
    • Heartflow’s stock rose in its first two days on public markets, closing at almost $30 on Monday. The company priced its IPO at $19 a share.

    Dive Insight:

    Heartflow has developed software for making 3D heart models from coronary computed tomography angiography scans. In a clinical trial, the company linked its lead product, Heartflow FFRCT Analysis, to a 78% improvement in identifying patients in need of revascularization.

    Heartflow was aiming to sell 12.5 million shares for between $15 and $17 each when it set its IPO range early this month. At the midpoint of the range, the company would have raised $200 million before fees under the original plan. 

    By the time Heartflow finalized the terms last week, the company had agreed to sell 16.7 million shares for $19 each. The changes increased the initial gross IPO amount to $316.7 million. Heartflow raised a further $47.5 million when underwriters took up their options to buy an additional 2.5 million shares in the overallotment. The company estimates net proceeds after fees will be $333.2 million.

    Heartflow’s first two days on public markets provided further evidence of investor enthusiasm. The stock closed at $28.75 on Friday. After peaking and troughing during Monday’s session, Heartflow closed up at just below $30. The closing price on Monday was almost 58% higher than the IPO price.

    The offering extends a recent uptick in IPO activity. Caris Life Sciences priced its IPO at $21 in June, having originally set a range of $16 to $18, and the precision medicine company’s stock closed above $30 on Monday. Carlsmed hit the middle of its expected $14 to $16 range, raising more than $100 million to advance its spine platform, but its share price had slipped to $13 by market close on Monday.



    Source link

    364M dive Heartflows IPO medtech raises
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleArintra Raises $21M to Expand Beyond Autonomous Medical Coding –
    Next Article How AI Agents Address Staffing Challenges and Burnout in Healthcare
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    SoundHealth Raises $12.25M to Expand Non-Invasive Medical Wearables

    29. Juli 2026
    News

    Aurenar Raises $5.7M to Scale Wireless V-Link Neuromodulation –

    29. Juli 2026
    News

    Inner Logic Raises $11.5M to Build Simulation Infrastructure for Procedural Devices

    28. Juli 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 2025468 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 2025423 Views

    Luna ring review | TechRadar

    26. Dezember 2025161 Views

    Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B

    20. Februar 2026152 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 2025468 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 2025423 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.